TY - JOUR
T1 - Structural analysis of binding functionality of folic acid-PEG dendrimers against folate receptor
AU - Sampogna-Mireles, Diana
AU - Araya-Durán, Ingrid D.
AU - Márquez-Miranda, Valeria
AU - Valencia-Gallegos, Jesús A.
AU - González-Nilo, Fernando D.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Dendrimers functionalized with folic acid (FA) are drug delivery systems that can selectively target cancer cells with folate receptors (FR-α) overexpression. Incorporation of polyethylene glycol (PEG) can enhance dendrimers solubility and pharmacokinetics, but ligand-receptor binding must not be affected. In this work we characterized, at atomic level, the binding functionality of conventional site-specific dendrimers conjugated with FA with PEG 750 or PEG 3350 as a linker. After Molecular Dynamics simulation, we observed that both PEG's did not interfere over ligand-receptor binding functionality. Although binding kinetics could be notably affected, the folate fragment from both dendrimers remained exposed to the solvent before approaching selectively to FR-α. PEG 3350 provided better solubility and protection from enzymatic degradation to the dendrimer than PEG 750. Also, FA-PEG3350 dendrimer showed a slightly better interaction with FR-α than FA-PEG750 dendrimer. Therefore, theoretical evidence supports that both dendrimers are suitable as drug delivery systems for cancer therapies.
AB - Dendrimers functionalized with folic acid (FA) are drug delivery systems that can selectively target cancer cells with folate receptors (FR-α) overexpression. Incorporation of polyethylene glycol (PEG) can enhance dendrimers solubility and pharmacokinetics, but ligand-receptor binding must not be affected. In this work we characterized, at atomic level, the binding functionality of conventional site-specific dendrimers conjugated with FA with PEG 750 or PEG 3350 as a linker. After Molecular Dynamics simulation, we observed that both PEG's did not interfere over ligand-receptor binding functionality. Although binding kinetics could be notably affected, the folate fragment from both dendrimers remained exposed to the solvent before approaching selectively to FR-α. PEG 3350 provided better solubility and protection from enzymatic degradation to the dendrimer than PEG 750. Also, FA-PEG3350 dendrimer showed a slightly better interaction with FR-α than FA-PEG750 dendrimer. Therefore, theoretical evidence supports that both dendrimers are suitable as drug delivery systems for cancer therapies.
KW - Dendrimer
KW - Drug delivery system
KW - Folate receptor
KW - Folic acid
KW - Molecular dynamics
KW - PEG
UR - http://www.scopus.com/inward/record.url?scp=85010190433&partnerID=8YFLogxK
U2 - 10.1016/j.jmgm.2017.01.004
DO - 10.1016/j.jmgm.2017.01.004
M3 - Article
AN - SCOPUS:85010190433
SN - 1093-3263
VL - 72
SP - 201
EP - 208
JO - Journal of Molecular Graphics and Modelling
JF - Journal of Molecular Graphics and Modelling
ER -